Novel side chain of 25-hydroxyitamin D2 series medicines and preparation method thereof

A technology of hydrocarbon group and amino group, applied in the field of preparation of common side chains, can solve the problems of low yield, limitation, difficult synthesis and purification, etc., and achieve the effects of high yield, easy product and short route.

Active Publication Date: 2011-01-26
SHANGHAI HAOYUAN CHEMEXPRESS
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Compound 5 not only has a low yield when it is used for drug synthesis, but also the synthesis and purification of compoun

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel side chain of 25-hydroxyitamin D2 series medicines and preparation method thereof
  • Novel side chain of 25-hydroxyitamin D2 series medicines and preparation method thereof
  • Novel side chain of 25-hydroxyitamin D2 series medicines and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

Its synthetic route is as follows:

Dissolve (R)-methyl 3-hydroxy-2-methylpropanoate (11.8 g, 100 mmol) in diethyl ether, and add MeMgBr (3M, 100 mL, 300 mmol) dropwise to it in an argon atmosphere at zero degrees Celsius. Then, continue stirring for 6 hours, slowly drop 1M hydrochloric acid into it to quench the reaction, extract with ethyl acetate (300 mL each time) three times, combine the organic phases, dry over anhydrous magnesium sulfate, filter and concentrate to obtain a colorless oily substance 11 (10.7 g ) with a yield of 90%. 1 H NMR (300MHz, δ, ppm) 0.81 (3H, d, J=6.9 Hz), 1.14 (3H, s), 1.22 (3H, s), 1.77 (1H, m), 3.58 (1H, b), 3.66 (2H, m), 3.84 (1H, b). 13 C NMR (75MHz, δ, ppm) 12.9, 23.9, 29.6, 43.9, 66.1, 74.5. ESI-HRMS (m / z) [M + ]118.0, 100.0, 85.0, 59.0.

The colorless oil obtained above was dissolved in dichloromethane (100 mL) and pyridine (10 mL), to which were added 4-(N,N-dimethylamino)pyridine (1 g) and p-toluenesulfonyl chloride (20 g, 105mmol)...

Example Embodiment

Its synthetic route is as follows:

Dissolve (R)-ethyl 3-hydroxy-2-methylpropanoate (11.8 g, 100 mmol) in ether, add MeLi (1 M, 300 mL, 300 mmol) dropwise to it at zero degrees Celsius under argon atmosphere, and finish dropping Then, continue to stir for 6 hours, slowly drop 1M hydrochloric acid into it to quench the reaction, extract with ethyl acetate (300 mL each time) three times, combine the organic phases, dry over anhydrous magnesium sulfate, filter and concentrate to obtain a colorless oily substance 11 (10.1 g ), the yield is 85%.

The colorless oil obtained above was dissolved in dichloromethane (100 mL) and triethylamine (10 mL), and methanesulfonyl chloride (11.4 g, 100 mmol) was added to it under cooling in an ice-salt bath, and stirring was continued for 2 hours until the raw materials disappeared. , water was added to quench the reaction, the solution was separated, the aqueous phase was extracted with dichloromethane (200 mL) three times, dried over anhydrou...

Example Embodiment

Example 1: Compound 1a, its molecular structure is as follows, wherein R1=R2=OCH2CH3, R=CH2OCH3.

Its synthetic route is as follows:

Dissolve the above p-toluenesulfonate 12 (13.6g, 50mmol) in dry CH2C12 (100mL), add pyridine (10g) and 4-(N,N-dimethylamino)pyridine to it under ice-water bath cooling , and then slowly dropwise added benzoyl chloride (10 g). After reacting at room temperature for 12 hours, the mixture was washed with water, and the aqueous phase was extracted with CH2Cl2. The organic phases were combined, dried over anhydrous sodium sulfate, filtered and concentrated, and the residue was purified by silica gel column chromatography to obtain the product 18 (13 g) in a yield of 78%.

The above mesylate 18 (11.3 g) was dissolved in dry CH3CN (100 mL), anhydrous NaI (5 g) was added to it, heated under reflux for 5 hours, concentrated to remove CH3CN, added with ether (100 mL), filtered, and filtered with ether (200 mL) to wash the filter cake, the combined filtr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation of organic compounds, in particular to a preparation method of a common side chain of a series of 25-hydroxyitamin D2 medicines. The structure of the compounds is represented in the formula 1. The compounds have wide application and are more stable than the traditional compounds with the same application, so that the compounds are convenient to storage and use. The method for synthesizing the target compounds (1) has high yield, short synthesis route and easily purified products.

Description

technical field The present invention relates to a method for preparing an organic compound, specifically a method for preparing a series of common side chains of 25-hydroxyvitamin D2 drugs, the structure of which is shown in Formula 1 below. Formula 1 Among them, R is a hydrogen atom or -SiR 3 R 4 R 5 or -R 3 or -R 6 OR 4 or -C(=O)R 3 , where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 are hydrocarbyl or hydrocarbyloxy or amino or hydrocarbyl-substituted amino, and they may be the same or different. Background technique Formula 2 Formula 3 A series of 25-hydroxyvitamin D2 drugs shown in formula 2 have a common side chain, and these drugs can be synthesized from compound 1 through the process shown in formula 3. These drugs include 25-hydroxyvitamin D2, 1a, 25-dihydroxyvitamin D2, paricalcitol, and others. These drugs are regulators of calcium and phosphorus homeostasis in animals and humans 1,2 . Recent studies have also identified their activity in cell ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07F9/40C07F9/655C07F9/53
Inventor 高强薛吉军郑保富刘荣
Owner SHANGHAI HAOYUAN CHEMEXPRESS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products